High-Z Nanoparticle Radiosensitization Timing for Tumor Dose

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current radiation therapy for tumors faces challenges in optimizing the concentration and distribution of radiosensitizing nanoparticles within tumors while minimizing their presence in surrounding healthy tissues, with existing nanoparticles having limited persistence and targeting efficiency.

Innovation Solution

A method involving two injections of high-Z element-containing nanoparticles, with the first injection 2-10 days prior to irradiation and a second injection 1-12 hours prior, using nanoparticles with atomic numbers above 40 and a mean hydrodynamic diameter below 10 nm, specifically designed to enhance radiation therapy by prolonging nanoparticle persistence in tumors and optimizing their distribution.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Power

If nanoparticles are injected immediately before irradiation, then radiation dose deposition is enhanced, but nanoparticle persistence in tumors is insufficient

Engineering Contradiction:
Improveradiation dose depositionVSAvoidnanoparticle persistence
Core Design Contradiction:
PowerVSDuration of action of moving object

Solution Approach 1:

The patent applies preliminary action by injecting nanoparticles 2-10 days before irradiation instead of immediately before treatment. This advance timing allows nanoparticles to accumulate and persist in tumor tissues, ensuring sufficient concentration is present when radiation is administered. The first injection establishes baseline nanoparticle presence, while a second injection 1-12 hours before irradiation optimizes tumor concentration at the moment of treatment.

Inventive Principle:
Principle #10Preliminary action

2Quantity of substance

If nanoparticle concentration in tumors is increased, then radiosensitizing effect is improved, but presence in healthy tissues increases causing side effects

Engineering Contradiction:
Improvenanoparticle concentration in tumorsVSAvoidside effects on healthy tissues
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent applies local quality by optimizing nanoparticle distribution specifically in tumor tissues through controlled injection timing. The 2-10 day pre-injection period allows nanoparticles to selectively accumulate in tumors via enhanced permeability and retention (EPR) effect, achieving high local concentration in the target while maintaining lower concentrations in healthy tissues. This spatial differentiation of nanoparticle concentration maximizes therapeutic effect while minimizing systemic toxicity.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly enhances the efficacy of radiation therapy by maintaining nanoparticles in tumors for an extended period, improving radiation dose deposition and reducing side effects on healthy tissues, as demonstrated by prolonged MRI signal enhancements and nanoparticle concentration in clinical trials.

Implementation Method 1

Considering that the radiation dose absorbed by any tissues is related to the square of relative atomic number (Z2) of the material

Methodology Applied
Scientific EffectPhotoelectric effect: Photoelectric Effect

Implementation Method 2

Under exposure to ionizing radiations, heavy-metal based nanoparticles produce photons and Auger electrons that improve the total dose rate deposition into the tumors

Methodology Applied
Scientific EffectAuger electron emission: Auger Effect

Implementation Method 3

induce the production of reactive oxygen species (ROS) and cause cellular damages on many tumors

Methodology Applied
Scientific EffectRadiation-induced reactive oxygen species production: Radiation

Data Source

PatentUS20220249711A1Methods for treating tumors
Publication Date: 2022.08.11 LYON INGENIERIE PROJETS
  • US20220249711A1 patent drawing
  • US20220249711A1 patent drawing
  • US20220249711A1 patent drawing

AI summary

The disclosure relates to methods for treating tumors. In particular, the disclosure relates to a method of treating a tumor by ionizing radiations in a subject in need thereof, said method comprising the steps of:(i) injecting a first therapeutically effective amount of high-Z element containing nanoparticles as radiosensitizing agents in said subject in need thereof within a period between 2 and 7 days prior to the first irradiation of the tumor,(ii) injecting a second therapeutically effective amount of the same or different high-Z element containing nanoparticles within a period between 1 hour to 12 hours prior to the first irradiation of the tumor, and,(iii) irradiating the tumor of said subject with a therapeutically efficient dose of radiations;wherein said high-Z element containing nanoparticles are nanoparticles containing an element with an atomic Z number higher than 40 and said nanoparticles have a mean hydrodynamic diameter below 10 nm.